SLAS Technology Volume 36 Outlines the Convergence of AI, Synthetic Biology, and Modular Digital Laboratory Infrastructures

SLAS Technology Volume 36 reveals the next era of intelligent lab automation, from AI-driven drug discovery to low-cost robotics and synthetic biology.

By: AXL Media

Published: Mar 26, 2026, 7:34 AM EDT

Source: Information for this report was sourced from SLAS (Society for Laboratory Automation and Screening)

Accelerating Drug Discovery Through Integrated Mass Spectrometry

The current editorial in SLAS Technology highlights a transformative shift in drug discovery enabled by the pairing of high-throughput experimentation with mass spectrometry. This combination allows researchers to perform parallel analysis on thousands of chemical reactions simultaneously, drastically reducing the time required for biological assays. While the field continues to navigate obstacles such as complex data management and matrix effects, the integration of artificial intelligence and direct-to-biology workflows is creating a more optimized, end-to-end discovery process. This technological evolution is moving the industry toward a model where chemical analysis and biological verification occur in nearly real-time.

The Rise of Machine Learning in Compound Property Prediction

A second featured editorial outlines the success of the joint challenge between EU-OPENSCREEN and SLAS, which focused on predicting the spectral properties of various compounds. This initiative underscores the critical importance of open-source, well-curated experimental datasets in training advanced machine learning models. By fostering a collaborative environment where researchers can test predictive algorithms against standardized data, the society is accelerating the development of tools that can identify therapeutic targets with greater accuracy. The winning solutions of this challenge are expected to provide a technical blueprint for the next generation of predictive software in medicinal chemistry.

Frameworks for Fully Autonomous Synthetic Biology

In a comprehensive review, researchers propose a dual-layered framework for integrating robotics and intelligent agents within synthetic biology. This conceptual model covers both "total automation" of the Design-Build-Test-Learn cycle and "progressive automation" that can be customized for specific laboratory contexts. The review addresses the significant physical and cognitive progress made in laboratory robotics while cautioning about the ethical implications of increasingly autonomous biological research. By creating a roadmap for AI-driven laboratories, the authors provide a vision for facilities that can execute complex genetic engineering tasks with minimal human intervention.